首页> 美国卫生研究院文献>Infection and Immunity >Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region
【2h】

Protective Immune Responses to the 42-Kilodalton (kDa) Region of Plasmodium yoelii Merozoite Surface Protein 1 Are Induced by the C-Terminal 19-kDa Region but Not by the Adjacent 33-kDa Region

机译:对约氏疟原虫裂殖子表面蛋白1的42-千达尔顿(kDa)区的保护性免疫反应是由C端19-kDa区而不是由邻近的33-kDa区诱导的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccination of mice with the 42-kDa region of Plasmodium yoelii merozoite surface protein 1 (MSP142) or its 19-kDa C-terminal processing product (MSP119) can elicit protective antibody responses in mice. To investigate if the 33-kDa N-terminal fragment (MSP133) of MSP142 also induces protection, the gene segment encoding MSP133 was expressed as a glutathione S-transferase (GST) fusion protein. C57BL/6 and BALB/c mice were immunized with GST-MSP133 and subsequently challenged with the lethal P. yoelii YM blood stage parasite. GST-MSP133 failed to induce protection, and all mice developed patent parasitemia at a level similar to that in naive or control (GST-immunized) mice; mice immunized with GST-MSP119 were protected, as has been shown previously. Specific prechallenge immunoglobulin G (IgG) antibody responses to MSP1 were analyzed by enzyme-linked immunosorbent assay and immunofluorescence. Despite being unprotected, several mice immunized with MSP133 had antibody titers (of all IgG subclasses) that were comparable to or higher than those in mice that were protected following immunization with MSP119. The finding that P. yoelii MSP133 elicits strong but nonprotective antibody responses may have implications for the design of vaccines for humans based on Plasmodium falciparum or Plasmodium vivax MSP142.
机译:用约氏疟原虫裂殖子表面蛋白1(MSP142)的42 kDa区域或其19 kDa C末端加工产物(MSP119)进行的疫苗接种可引起小鼠的保护性抗体应答。为了研究MSP142的33 kDa N末端片段(MSP133)是否也诱导保护作用,将编码MSP133的基因片段表达为谷胱甘肽S-转移酶(GST)融合蛋白。用GST-MSP133免疫C57BL / 6和BALB / c小鼠,然后用致死性约氏疟原虫YM血期寄生虫攻击。 GST-MSP133未能诱导保护作用,并且所有小鼠都发生了寄生性寄生虫血症,其水平与幼稚或对照(经GST免疫的)小鼠相似。如前所述,用GST-MSP119免疫的小鼠受到保护。通过酶联免疫吸附测定和免疫荧光分析了对MSP1的特异性攻击前免疫球蛋白G(IgG)抗体反应。尽管没有受到保护,但用MSP133免疫的几只小鼠的抗体滴度(在所有IgG亚类中)与MSP119免疫后被保护的小鼠的抗体滴度相当或更高。约氏疟原虫MSP133引发强烈但无保护性的抗体反应的发现可能对基于恶性疟原虫或间日疟原虫MSP142的人用疫苗设计具有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号